Please login to the form below
Live panel discussion: Should diverse representation in UK clinical trials be mandatory?
This online event is being held by Innovative Trials, COUCH Health, and Egality Health. Three organisations who are working to improve diversity in clinical trials.
Live panel discussion | Tuesday 10 November 2020 | 12:30–14:00 GMT / 07:30–09:00 EST
Sign up to attend the discussion here: https://www.clinicaltrialdiversity.info/
In 2019, of the ~46,000 clinical research volunteers involved in clinical trials that resulted in novel drug approvals only 18% were Hispanic, 9% were African American, and 9% were Asian. Patient diversity is a problem that exists in clinical trials. Participants across all therapeutic areas have tended to be Caucasian and male.
There is a recognised need to challenge the disproportionate representation in research that affects population health. In the US, for example, the FDA is placing increasing pressure on pharma companies to run trials with patients who better resemble the overall population; a scramble is on to make trials more diverse.
The FDA guidance on patient diversity does not specifically dictate what companies should do to make their trials more diverse. However, it does state trials should recruit patients that represent the population that has the burden of disease in the real world.
Is it time for the UK to do the same?
The COVID-19 pandemic has exposed persisting health inequalities in the UK, and the need for effective medical research that meets the needs of those most affected. In the current climate in the UK, more than ever, there is an urgent need to tackle systemic inequalities and under-representation of cultures, races, nationalities across all segments of industry, and society as a whole.
Furthermore, given the steps the FDA has taken to address disproportionate representation in clinical trials in the US, this event enables organsations involved to move ahead of the curve and foster an early discussion on this issue specifically within the UK context.
Sign up to attend the discussion here: https://www.clinicaltrialdiversity.info/
Company Details
COUCH Health
Address:
Suite 2.10, Jactin House
24 Hood Street
Manchester
M4 6WX
United Kingdom
Latest content on this profile
- COUCH Health publishes report to encourage patient engagement in the MedTech sector
- Manchester, UK, 27 February 2023 — COUCH Health today announced the publication of a new report “The Power of Patient Engagement in MedTech”.
COUCH Health
- #DemandDiversity: Why cultural safety is an important step towards achieving diversity in clinical trials
- In our recent Demand Diversity research, a Black American participant said, “I wish people were more educated. Doctors are supposed to treat everyone the same, not have favourites. They need unconscious bias training.”
COUCH Health
- How do ethnic minority groups in the U.S. view clinical trials?
- This year, we decided to do the same with ethnic minority communities over in the United States (U.S.) too. Ultimately, we wanted to explore attitudes towards clinical trials from these communities, understand the barriers in participation, and determine what factors may influence people’s decisions to take part.
COUCH Health
- Three things to consider when using social listening research for patient recruitment
- We are looking at how patient research can power your patient recruitment campaign. A look into social listening follows on from this blog perfectly, offering a stronger and more authentic alternative to relying on data trends to guide your activities. So, let’s get started…
COUCH Health
- 4 ways mobile ethnography studies can elevate your patient insights
- How can we achieve more real-life, in-the-moment insights from different groups to understand their thoughts and behaviours? This is where ethnography studies come in.
COUCH Health
- #DemandDiversity: We’re calling on the clinical trials industry to include us all
- The lack of diversity in clinical trials is something we’ve spoken about time and time again. By now, you might think we sound a bit like a broken record. But, the fact is, many people still aren’t aware of the underrepresentation, especially those who don’t work in the industry. Do you think if the clinical research industry could see the people they were leaving out of clinical trials, and hear how they felt about being underrepresented, it would make a difference?
COUCH Health
